Literature DB >> 15868425

Post-transcriptional operons and regulons co-ordinating gene expression.

Jack D Keene1, Patrick J Lager.   

Abstract

Experiments reported over the past several years, including genome-wide microarray approaches, have demonstrated that many eukaryotic RNA-binding proteins (RBPs) associate with multiple messenger RNAs (mRNAs) both in vitro and in vivo. This multi-targeted binding property of RBPs has led to a model of regulated gene expression in eukaryotes that we termed the post-transcriptional operon. This concept was established by an analogy between polycistronic mRNAs that are generated from bacterial operons, and the co-ordinated regulation of multiple monocistronic mRNAs by RBPs. Post-transcriptional operons represent a powerful mechanism to organize and express genetic information as functionally related combinations of monocistronic mRNAs. In fact, much of the diversification of individual proteomes may be determined by the combinatorial properties of post-transcriptional operons. This review examines data supporting the role of post-transcriptional operons and regulons in organizing genetic information and co-ordinating expression of functionally related transcripts from their origins at transcription to their subsequent splicing, export and translation.

Mesh:

Substances:

Year:  2005        PMID: 15868425     DOI: 10.1007/s10577-005-0848-1

Source DB:  PubMed          Journal:  Chromosome Res        ISSN: 0967-3849            Impact factor:   5.239


  53 in total

1.  Evolutionary Conservation and Diversification of Puf RNA Binding Proteins and Their mRNA Targets.

Authors:  Gregory J Hogan; Patrick O Brown; Daniel Herschlag
Journal:  PLoS Biol       Date:  2015-11-20       Impact factor: 8.029

Review 2.  Insights into the structural basis of RNA recognition by STAR domain proteins.

Authors:  Sean P Ryder; Francesca Massi
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

3.  Intrinsic mRNA stability helps compose the inflammatory symphony.

Authors:  Paul Anderson
Journal:  Nat Immunol       Date:  2009-03       Impact factor: 25.606

4.  Decreased up-regulation of the interleukin-12Rbeta2-chain and interferon-gamma secretion and increased number of forkhead box P3-expressing cells in patients with a history of chronic Lyme borreliosis compared with asymptomatic Borrelia-exposed individuals.

Authors:  S Jarefors; C K Janefjord; P Forsberg; M C Jenmalm; C Ekerfelt
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

Review 5.  Control of messenger RNA fate by RNA-binding proteins: an emphasis on mammalian spermatogenesis.

Authors:  R Keegan Idler; Wei Yan
Journal:  J Androl       Date:  2011-07-14

6.  Persistent redistribution of poly-adenylated mRNAs correlates with translation arrest and cell death following global brain ischemia and reperfusion.

Authors:  J T Jamison; F Kayali; J Rudolph; M Marshall; S R Kimball; D J DeGracia
Journal:  Neuroscience       Date:  2008-04-01       Impact factor: 3.590

7.  Genome-wide identification of mRNAs associated with the translational regulator PUMILIO in Drosophila melanogaster.

Authors:  André P Gerber; Stefan Luschnig; Mark A Krasnow; Patrick O Brown; Daniel Herschlag
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

8.  Molecular composition of staufen2-containing ribonucleoproteins in embryonic rat brain.

Authors:  Marjolaine Maher-Laporte; Frédéric Berthiaume; Mireille Moreau; Louis-André Julien; Gabriel Lapointe; Michael Mourez; Luc DesGroseillers
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

9.  Coordinated posttranscriptional mRNA population dynamics during T-cell activation.

Authors:  Neelanjan Mukherjee; Patrick J Lager; Matthew B Friedersdorf; Marshall A Thompson; Jack D Keene
Journal:  Mol Syst Biol       Date:  2009-07-28       Impact factor: 11.429

10.  Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.

Authors:  Biljana Culjkovic; Katherine L Borden
Journal:  J Oncol       Date:  2009-12-13       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.